Volume 80, Issue 4 pp. 343-351
Research Article
Full Access

Mutation analysis of Gaucher disease patients from Argentina: High prevalence of the RecNciI mutation

Bru Cormand

Bru Cormand

Departament de Genètica, Universitat de Barcelona, Barcelona, Spain

Search for more papers by this author
Theresa L. Harboe

Theresa L. Harboe

Departament de Genètica, Universitat de Barcelona, Barcelona, Spain

Search for more papers by this author
Laura Gort

Laura Gort

Institut de Bioquímica Clínica, Barcelona, Spain

Search for more papers by this author
Cristina Campoy

Cristina Campoy

Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina

Search for more papers by this author
Mariana Blanco

Mariana Blanco

Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina

Search for more papers by this author
Néstor Chamoles

Néstor Chamoles

Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina

Search for more papers by this author
Amparo Chabás

Amparo Chabás

Institut de Bioquímica Clínica, Barcelona, Spain

Search for more papers by this author
Lluïsa Vilageliu

Lluïsa Vilageliu

Departament de Genètica, Universitat de Barcelona, Barcelona, Spain

Search for more papers by this author
Daniel Grinberg

Corresponding Author

Daniel Grinberg

Departament de Genètica, Universitat de Barcelona, Barcelona, Spain

Departament de Genètica, Facultat de Biologia, Universitat de Barcelona; Av. Diagonal, 645; 08071 Barcelona, SpainSearch for more papers by this author

Abstract

Gaucher disease (GD) is caused by a deficiency of β-glucocerebrosidase activity mainly due to mutations in the gene coding for the enzyme. More than 100 mutations have been identified to date and their frequencies have been established in several populations, including Ashkenazi Jews, among whom the disease is particularly prevalent. In order to study the molecular pathology of the disease in patients from Argentina, we conducted a systematic search for mutations in the glucocerebrosidase gene. Genomic DNA from 31 unrelated GD patients was screened for seven previously described mutations: N370S (1226A→G), L444P (1448T→C), D409H (1342G→C), R463C (1504C→T), 1263del55, RecNciI, and RecTL. This allowed the identification of 77.4% of the GD alleles: N370S and RecNciI were the most prevalent mutations found (46.8% and 21% respectively). Southern analysis demonstrated three distinct patterns for the RecNciI alleles. In order to identify the remaining alleles, the full coding region of the gene, all the splice sites, and part of the promoter region were analyzed by single-strand conformational polymorphism analysis (SSCP) after polymerase chain reaction amplification. This extensive screening allowed the identification of 13 different mutations, accounting for 93% of the total number of GD alleles. Three novel missense mutations, I161S (599T→G), G265D (911G→A), and F411I (1348T→A), were detected. Twelve polymorphic sites within the glucocerebrosidase gene are in complete linkage disequilibrium and define two major haplotypes, “−” and “+”. Mutation N370S was always associated with the “−” haplotype, as described in other populations. Interestingly, the RecNciI alleles with the same Southern-blot pattern were always associated with the same haplotype. Am. J. Med. Genet. 80:343–351, 1998. © 1998 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.